By situating our results alongside prior findings that examine sex, tumor biology, timing, and PD-L1 status as potential moderators, we extend the literature by offering a comprehensive, model-driven meta-analytic comparison focused on survival and risk outcomes within a single tumor type. The gene discussed is CD274; the disease is neoplasm.